Zobrazeno 1 - 10
of 3 702
pro vyhledávání: '"Janssen Rs"'
Autor:
Richmond P; University of Western Australia School of Medicine, Department of Immunology, Perth Children's Hospital and Telethon Kids Institute, Nedlands, WA, Australia., Nolan T; Vaccine and Immunisation Research Group (VIRGo), Peter Doherty Institute for Infection and Immunity at the University of Melbourne and Murdoch Children's Research Institute, Melbourne, VIC, Australia., McGirr A; Northern Beaches Clinical Research, Brookvale, NSW, Australia., Napier-Flood F; Paratus Clinical Research Western Sydney, Blacktown, NSW, Australia., Kim J; Paratus Clinical Research Central Coast, Kanwal, NSW, Australia., Leah A; Paratus Clinical Research Canberra, Bruce, ACT, Australia., Xie F; Dynavax Technologies Corporation, Emeryville, CA, USA., Campbell JD; Dynavax Technologies Corporation, Emeryville, CA, USA., Godeaux O; ZAM Consulting, Brussels, Belgium., Henry O; Dynavax Technologies Corporation, Emeryville, CA, USA., Wood N; Kids Research, The Children's Hospital at Westmead, Westmead, NSW, Australia., Janssen RS; Dynavax Technologies Corporation, Emeryville, CA, USA. Electronic address: rjanssen@dynavax.com.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126251. Date of Electronic Publication: 2024 Sep 02.
Autor:
Girndt M; Department of Internal Medicine II, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, Halle 06120, Germany., Houser P; Amherst Family Practice, 1867 Amherst Street, Winchester, VA 22601, USA., Manllo-Karim R; Gamma Medical Research, Inc., 222 East Ridge Road, Suite 214, Mcallen, TX 78503, USA., Ervin JE; Center for Pharmaceutical Research, 1010 Carondelet Drive, Suite 426, Kansas City, MO 64114, USA., Charytan C; New York-Presbyterian Queens, 56-45 Main Street, Flushing, NY 11355, USA., Chow S; Department of Medicine, Michael Garron Hospital, 825 Coxwell Avenue, Toronto, ON, Canada., Symonian-Silver M; National Institute of Clinical Research, 1000 Corporate Center Drive, Suite 330, Monterey Park, CA 91754, USA., Lehrner L; Kidney Specialists of Southern Nevada, 500 S Rancho Drive, #12, Las Vegas, NV 89106, USA., Linfert D; Nephrology Associates, 28 White Bridge Pike, Suite 300, Nashville, TN 37205, USA., Shemin D; Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA., Michelsen A; Gemeinschaftspraxis für Innere Medizin, Pferdebachstr. 29, 58455 Witten, Germany., Xie F; Dynavax Technologies Corporation, 2100 Powell Street, Suite 720, Emeryville, CA 94608, USA., Janssen RS; Dynavax Technologies Corporation, 2100 Powell Street, Suite 720, Emeryville, CA 94608, USA. Electronic address: rjanssen@dynavax.com.
Publikováno v:
Vaccine [Vaccine] 2023 May 11; Vol. 41 (20), pp. 3224-3232. Date of Electronic Publication: 2023 Apr 19.
Autor:
Girndt M; Department of Internal Medicine II, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Plüer M; Nephrology, KfH-Nierenzentrum Berlin-Neukölln, in Berlin-Neukölln, Germany., Dellanna F; Kidney and Dialysis Center, MVZ DaVita Rhein Ruhr, Düsseldorf, Germany., Michelsen AK; Internal Medicine, MVZ Lütten Klein, Nephrocare Rostock GmbH, Rostock, Germany., Beige J; Department of Nephrology and Kuratorium for Dialysis and Transplantation Renal Unit, Hospital St. Georg, Martin-Luther-University Halle/Wittenberg, Leipzig, Germany., Toussaint K; Lipid Clinic, Nephrocare Hamburg-Barmbek, Hamburg, Germany., Wehweck HJ; Internal Medicine, KfH, Nierenzentrum, Munich, Germany., Koch M; Center of Nephrology, Mettmann, Germany., Hafezi Rachti S; Nierenzentrum Mannheim, Mannheim-Käfertal, Germany., Faust J; Internal Medicinem Regulatory and Medical Affairs, Nephrologische Gemeinschaftspraxis, Mainz, Germany., Bosselmann HP; Klinik für Nieren- und Hochdruckkrankheiten and Bereich Endokrinologie und Stoffwechselkrankheiten, Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany., Witzke O; Department of Infectious Diseases, West German Centre of Infectious Diseases, Universitätsmedizin Essen, University Duisburg-Essen, Essen, Germany., Janssen RS; Dynavax Technologies Corporation, Emeryville, California, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2136912. Date of Electronic Publication: 2022 Oct 21.
Autor:
Janssen RS (AUTHOR), Holtgrave DR (AUTHOR), Valdiserri RO (AUTHOR), Shepherd M (AUTHOR), Gayle HD (AUTHOR), De Cock KM (AUTHOR)
Publikováno v:
American Journal of Public Health. Jul2001, Vol. 91 Issue 7, p1019-1024. 6p.
Autor:
Janssen RS; Clinical Development, Dynavax Technologies, 2100 Powell St, Emeryville, CA 94608, USA. Electronic address: rjanssen@dynavax.com., Bruxvoort K; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 S Los Robles Ave, Pasadena, CA 91101, USA., Jacobsen SJ; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 S Los Robles Ave, Pasadena, CA 91101, USA., Slezak J; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 S Los Robles Ave, Pasadena, CA 91101, USA., David C; Market Access and Policy, Dynavax Technologies, 2100 Powell St, Emeryville, CA 94608, USA., Hyer R; Medical Affairs, Dynavax Technologies, 2100 Powell St, Emeryville, CA 94608, USA., Poland GA; Mayo Vaccine Research Group, Mayo Clinic, 200 1st St, SW Rochester, MN 55905, USA.
Publikováno v:
Vaccine [Vaccine] 2021 Sep 15; Vol. 39 (39), pp. 5666-5672. Date of Electronic Publication: 2021 Aug 14.
Autor:
Hirst A; Global HTA, Health Economics, Reimbursement and Outcomes, ICON plc, Dublin, Ireland., Hyer RN; Clinical Development, Dynavax Technologies Corporation, Emeryville, CA, USA. Electronic address: Randall.Hyer@modernatx.com., Janssen RS; Clinical Development, Dynavax Technologies Corporation, Emeryville, CA, USA. Electronic address: rjanssen@dynavax.com.
Publikováno v:
Vaccine [Vaccine] 2021 Jul 30; Vol. 39 (33), pp. 4733-4741. Date of Electronic Publication: 2021 May 21.
Autor:
Awad AM; Clinical Research Consultants, 3930 Washington Street, Kansas City, MO 64111, United States., Ntoso A; DaVita Franklin Dialysis, 150 South Independence Mall West, 101 Public Ledger Bldg, Philadelphia, PA 19106, United States., Connaire JJ; DaVita Clinical Research, 825 South 8th Street, Suite 300, Minneapolis, MN, United States., Hernandez GT; El Paso Kidney Specialists, 1310 Murchison Drive, Suite 100, El Paso, TX 79902, United States., Dhillon K; DaVita Clinical Research - Norfolk, 962 Norfolk Square, Norfolk, VA 23502, United States., Rich L; 2514 South 102nd Street, Suite 120, Wauwatosa, WI 53227, United States., Henderson H; 18001 East 10 Mile Road, Suite 3, Roseville, MI 48066, United States., Lynn R; Kidney Medical Associates, 34 Marconi Street, Suite 100, Bronx, NY 10461, United States., Hyer RN; Dynavax Technologies Corporation, 2100 Powell Street, Suite 900, Emeryville, CA 94608, United States., Xie F; Dynavax Technologies Corporation, 2100 Powell Street, Suite 900, Emeryville, CA 94608, United States., Erby K; Dynavax Technologies Corporation, 2100 Powell Street, Suite 900, Emeryville, CA 94608, United States., Janssen RS; Dynavax Technologies Corporation, 2100 Powell Street, Suite 900, Emeryville, CA 94608, United States. Electronic address: rjanssen@dynavax.com.
Publikováno v:
Vaccine [Vaccine] 2021 Jun 08; Vol. 39 (25), pp. 3346-3352. Date of Electronic Publication: 2021 May 14.
Autor:
Daniels, Joseph1,2 (AUTHOR) j.daniels@kbth.gov.gh, Nartey, Yvonne A.3 (AUTHOR), Djankpa, Francis4 (AUTHOR), Simpore, Jacques5 (AUTHOR), Obiri-Yeboah, Dorcas2 (AUTHOR)
Publikováno v:
PLoS ONE. 8/22/2024, Vol. 19 Issue 8, p1-16. 16p.
Autor:
Allan-Blitz, Lao-Tzu1,2 (AUTHOR) lallan-blitz@mgb.org, Mayer, Kenneth H2,3,4,5 (AUTHOR)
Publikováno v:
Open Forum Infectious Diseases. Aug2024, Vol. 11 Issue 8, p1-8. 8p.
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 39:446-453
The objectives were to compare the prevalence of high-risk sexual behaviors in HIV+ persons aware of their serostatus with that in HIV+ persons unaware of their status in the United States and to discuss implications for HIV prevention programs. A me